Matthew Briggs submitted his PhD thesis in 2018 at the University of Adelaide, which focused on MALDI mass spectrometry imaging of N-glycans on FFPE ovarian cancer tissue. He is now a Research Associate at the Future Industries Institute, University of South Australia, under the supervision of Prof. Peter Hoffmann where he focuses on the use of mass spectrometry for cancer, biopharma, food and environmental research.
About me
Matthew Briggs submitted his PhD thesis in 2018 at the University of Adelaide, which focused on MALDI mass spectrometry imaging of N-glycans on FFPE ovarian cancer tissue. He is now a Research Associate at the Future Industries Institute, University of South Australia, under the supervision of Prof. Peter Hoffmann where he focuses on the use of mass spectrometry for cancer, biopharma, food and environmental research.
About me
Doctor of Philosophy The University of Adelaide
Bachelor of Science with First Class Honours University of Adelaide
Bachelor of Science University of Adelaide
Research
Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2019 |
Open access
11
10
8
|
| 2019 |
Open access
7
1
2
|
| 2019 |
Open access
6
10
17
|
| 2019 |
3
3
6
|
| 2018 |
Open access
1
1
3
|
| 2017 |
Open access
13
11
2
|
| 2016 |
28
25
5
|
| 2016 |
Open access
61
62
7
|
| 2015 |
Open access
|
| 2015 |
Open access
33
52
6
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Bruker | AUSTRALIA |
| CSL Limited | AUSTRALIA |
| Griffith University | AUSTRALIA |
| Macquarie University | AUSTRALIA |
| Royal Adelaide Hospital | AUSTRALIA |
| SA Pathology | AUSTRALIA |
| University of Adelaide | AUSTRALIA |
| University of Science, Malaysia | MALAYSIA |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
